MAP2 and Alzheimer disease: By immunofluorescence, we show that um-PEA increases MAP2 expression in the CA1 zone of the hippocampus in 3×Tg-AD mice at 6 and 12 months of age, suggesting that um-PEA increases neuronal viability in this region, a key area for the mediation of memory formation and recall.